Skip to content

Crinetics Pharmaceuticals CRNX Prepaid & Other Current

Prepaid & Other Current at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$27.5M-76.9%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
$35.89M-9.3%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.22M+41.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$18.77M+33.9%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$6.41M-44.2%
United Therapeutics logo
United TherapeuticsUTHR
$228M+73.9%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.79B+21.9%

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's prepaid & other current?
Crinetics Pharmaceuticals (CRNX) reported prepaid & other current of $22.36M in Q1 2026.
How has Crinetics Pharmaceuticals's prepaid & other current changed year-over-year?
Crinetics Pharmaceuticals's prepaid & other current increased by 36.1% year-over-year, from $16.43M to $22.36M.
What is the long-term trend for Crinetics Pharmaceuticals's prepaid & other current?
Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's prepaid & other current has grown at a 22.0% compound annual growth rate (CAGR), from $6.61M to $17.84M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.